Related Experiment Video
Updated: Jul 15, 2026

Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
Pulmonary hypertension in congenital diaphragmatic hernia
Hadi Mohseni-Bod1, Desmond Bohn
1Department of Critical Care Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
Insights
Congenital diaphragmatic hernia (CDH) in newborns often causes pulmonary hypertension (PHTN), leading to heart and lung issues. Early intervention with PGE1 or iNO and supportive care improves outcomes for affected infants.
Area of Science:
- Neonatal Medicine
- Pediatric Cardiology
- Pulmonology
Background:
- Congenital diaphragmatic hernia (CDH) frequently presents with clinically significant pulmonary hypertension (PHTN) in neonates.
- This PHTN can cause right-to-left shunting, hypoxemia, and acute right heart failure, even in infants without obvious ductal shunting.
- Pulmonary vascular resistance and right ventricular pressures are often elevated in CDH, potentially persisting postnatally, with abnormal pulmonary vascular beds.
Purpose of the Study:
- To review the pathophysiology and management of pulmonary hypertension in infants with congenital diaphragmatic hernia.
- To highlight the impact of modern management strategies on mortality and morbidity.
- To discuss therapeutic interventions and long-term follow-up for CDH patients.
Main Methods:
- Review of clinical findings and diagnostic approaches for PHTN in CDH.
- Discussion of established and emerging treatment modalities for PHTN in this population.
- Emphasis on multidisciplinary care and long-term follow-up strategies.
Main Results:
- "Gentle" ventilation, delayed surgery, and improved peri-operative care have significantly reduced mortality over the past two decades.
- Prostaglandin E1 (PGE1) is recommended for hemodynamically significant PHTN with right ventricular dysfunction and restrictive patent ductus arteriosus (PDA).
- Inhaled nitric oxide (iNO) may be beneficial, with response confirmation via echocardiography.
Conclusions:
- Pulmonary hypertension is a critical issue in congenital diaphragmatic hernia requiring prompt recognition and management.
- Pharmacological interventions like PGE1 and iNO play a role in managing PHTN, alongside optimized ventilation and surgical timing.
- Long-term multidisciplinary follow-up is essential for managing chronic morbidities in survivors of CDH.
Abstract:
Clinically significant pulmonary hypertension (PHTN) is a common finding in newborn infants with congenital diaphragmatic hernia (CDH) resulting in right to left shunting at pre- and postductal level, hypoxemia, and acute right heart failure in those most severely affected. Even in those without clinical manifestations of ductal shunting, cardiac echo studies would suggest that increased pulmonary vascular resistance and right ventricular pressures are almost a universal finding in this disease, and in some instances, may persist well into the postnatal period. The lung is small and structurally abnormal, and the pulmonary vascular bed is not only reduced in size, but responds abnormally to vasodilators. During the last 20 years, "gentle" ventilation, delayed surgery, and improved peri-operative care have made the greatest impact in decreasing mortality in this condition. Use of PGE1 should be considered early if there is hemodynamically significant PHTN, right ventricular dysfunction, and the patent ductus arteriosus (PDA) is becoming restrictive. In individual patients, inhaled nitric oxide (iNO) might be helpful, but the response to iNO should be confirmed using echocardiography. In patients who survive operation and leave the hospital, there are chronic causes of morbidity that need to be looked for and managed in a multi-disciplinary follow-up clinic.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Pulmonary Cycle: Exhalation
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction